To determine whether IGF2BP2 promotes pancreatic cancer cell growth via the PI3K-Akt pathway in vivo as observed in vitro, we established a subcutaneous xenograft model with different treatments (Fig. 6a). Here, AKT1 is linked to familial pancreatic carcinoma.